Former U.S. President Bill Clinton and drugmakers Pfizer and Matrix Laboratories Ltd announced a deal on Thursday to lower the cost of treatments for patients with drug-resistant forms of HIV/AIDS.
Second-line antiretroviral therapies and a drug used to treat tuberculosis for those with drug-resistant HIV/AIDS will be made available at a reduced cost and in more convenient regimens, saving as many as hundreds of thousands of lives in the developing world.
Donald Trump announced a new package of tariffs on Tuesday, this time on generic drugs made...
One of the strictest abortion bans in the country will be on the ballot this November...
One in four Israelis now engages in harmful substance use as the psychological fallout from Israel’s...
